Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 3
2005 12
2006 27
2007 19
2008 21
2009 28
2010 54
2011 72
2012 63
2013 55
2014 73
2015 93
2016 103
2017 114
2018 133
2019 162
2020 184
2021 223
2022 259
2023 233
2024 273
2025 347
2026 226

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,492 results

Results by year

Filters applied: . Clear all
Page 1
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial.
Cloughesy TF, van den Bent MJ, Touat M, Blumenthal DT, Peters KB, Ellingson BM, Clarke JL, Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F, Umemura Y, Nabors B, Holdhoff M, Hottinger AF, Arakawa Y, Sepulveda JM, Wick W, Soffietti R, Perry J, Giglio P, de la Fuente M, Maher E, Bottomley A, Tron AE, Yi D, Zhao D, Pandya SS, Steelman L, Hassan I, Wen PY, Mellinghoff IK; INDIGO trial investigators. Cloughesy TF, et al. Among authors: zhao d. Lancet Oncol. 2025 Dec;26(12):1665-1675. doi: 10.1016/S1470-2045(25)00472-3. Epub 2025 Oct 29. Lancet Oncol. 2025. PMID: 41175888 Clinical Trial.
Macrophage PD-1 regulates energy expenditure and metabolic dysfunction under immune checkpoint blockade.
Wu MM, Yang YC, Hu ZQ, Chang JY, Xiao H, Miao C, Zhang BW, He ZX, Zhu D, Duan YR, Wang S, Liu JY, Guo ZP, Sun Y, Liu DY, Yu M, Zhang Y, Mao JJ, Jiang S, Zhang BK, Mei Z, Gao J, Liang C, Wang QS, Yu CJ, Zhao D, Yan CH, Li Y, Pan ZW, Chen Z, Xu DQ, Liu T, Ji Y, Zhang ZR. Wu MM, et al. Among authors: zhao d. Cell Metab. 2026 Jan 6;38(1):208-227.e12. doi: 10.1016/j.cmet.2025.11.009. Epub 2025 Dec 10. Cell Metab. 2026. PMID: 41380676
KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer.
Wei Y, Liu M, Yen EY, Yao J, Xun Z, Nguyen PT, Wang X, Yang Z, Yousef A, Pan D, Jin Y, Li CF, Theardy MS, Park J, Cai Y, Takeda M, Vasquez M, Park EM, Peng DH, Zhou Y, Zhao H, Heffernan TP, Viale A, Wang H, Watowich SS, Liang H, Zhao D, DePinho RA, Yao W, Ying H. Wei Y, et al. Among authors: zhao d. Cancer Res. 2025 Dec 1;85(23):4825-4838. doi: 10.1158/0008-5472.CAN-25-2024. Cancer Res. 2025. PMID: 40966362 Free PMC article.
GIPC1 governed ferroptosis by regulating DECR1-modulating lipid homeostasis during dilated cardiomyopathy (DCM).
Tang N, Mu R, Wang H, Wu J, Zhang J, Huang D, Han Y, Li W, Chen Y, Li X, Sun Y, Zhang Z, Zuo J, Hu Y, Yin Y, Qu Y, Liu J, Jiao L, Liu X, Liang H, Wang N, Bai Y, Liu Y, Wang B, Zhao D, Liu Y, Yang B. Tang N, et al. Among authors: zhao d. Cell Death Differ. 2026 Aug;33(8):1536-1551. doi: 10.1038/s41418-026-01679-9. Epub 2026 Mar 5. Cell Death Differ. 2026. PMID: 41787053 Free PMC article.
2,492 results